Kuk-Hyun Kyung
Direttore/Membro del Consiglio presso Aprinoia Therapeutics, Inc. /US/
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ming-Kuei Jang | M | 52 |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | 9 anni |
| Masaomi Miyamoto | M | 74 |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | 7 anni |
| Lana Gladstein | F | 48 |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | 1 anni |
| Roger Pomerantz | M | 67 |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | 1 anni |
| Mark Shearman | M | 62 |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | 1 anni |
| Xin Hui | M | 53 |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | 2 anni |
| Zhi Gang Luo | M | 53 |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | 3 anni |
| Brian Achenbach | M | 59 |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jae-Seung Yoon | M | 61 | 5 anni | |
| In-Joon Hwang | M | 58 | - | |
| Chang-Hyeon Song | M | 56 | - | |
| Gyu-Chan Jo | M | 59 | - | |
| M. S. Choudhary | M | - | - | |
| Nitin Hariyantlal Datanwala | M | 72 | - | |
| Yeong-Chan Yoon | M | 60 | - | |
| Min Kim | M | 50 | - | |
| Sanghun Kim | M | - | 8 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Corea del Sud | 9 | 52.94% |
| Isole Cayman | 8 | 47.06% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Kuk-Hyun Kyung
- Contatti personali
